Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1

We have previously reported that the CD14+ monocytic subpopulation of human PBMC induces programmed cell death (apoptosis) in cocultured endothelial cells (EC) when stimulated by bacterial endotoxin (LPS). Apoptosis is mediated by two routes, first via transmembrane TNF-α (mTNF) expressed on PBMC and, in addition, by TNF-independent soluble factors that trigger apoptosis in EC. Neutralizing anti-TNF mAb completely blocked coculture-mediated apoptosis, despite the fact that there should have been additional soluble cell death factors. This led to the hypothesis that a reverse signal is transmitted from the TNF receptor on EC to monocytes (MO) via mTNF that prevents the production of soluble apoptotic factors. Here we have tested this hypothesis. The results support the idea of a bidirectional cross-talk between MO and EC. Peripheral blood MO, MO-derived macrophages (MΦ), or the monocytic cell line Mono Mac 6 were preincubated with human microvascular EC that constitutively express TNF receptor type I (TNF-R1) and subsequently stimulated with LPS. Cell-free supernatants of these preparations no longer induced EC apoptosis. The preincubation of MO/MΦ with TNF-reactive agents, such as mAb and soluble receptors, also blocked the production of death factors, providing further evidence for reverse signaling via mTNF. Finally, we show that reverse signaling through mTNF mediated LPS resistance in MO/MΦ as indicated by the down-regulation of LPS-induced soluble TNF and IL-6 as well as IL-1 and IL-10.

[1]  P. Scheurich,et al.  Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses , 1990, The Journal of experimental medicine.

[2]  G. Kollias,et al.  Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. , 1996, Journal of inflammation.

[3]  C. Ferran,et al.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. , 1994, The Journal of clinical investigation.

[4]  F. Emmrich,et al.  Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. , 1986, Blood.

[5]  R. Andreesen,et al.  CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. , 1998, Journal of immunology.

[6]  M. Ueffing,et al.  Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. , 1995, Blood.

[7]  A. Karsan,et al.  Modulation of endothelial cell apoptosis: mechanisms and pathophysiological roles. , 1996, Journal of atherosclerosis and thrombosis.

[8]  E. Holler,et al.  Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. , 1997, Blood.

[9]  M. Wittmann,et al.  Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide. , 1999, Blood.

[10]  N. Shen,et al.  Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells , 1992, Journal of cellular biochemistry.

[11]  Volker Herzog,et al.  Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes , 1988, International journal of cancer.

[12]  D. Wallach,et al.  Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. , 1995, Journal of inflammation.

[13]  L. Gooding,et al.  A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.

[14]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[15]  D. Green,et al.  Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. , 1992, Cancer research.

[16]  Pamela J. Fink,et al.  Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand , 1998, The Journal of experimental medicine.

[17]  David Wallach,et al.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ , 1999, The EMBO journal.

[18]  P. Lipsky,et al.  Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. , 1997, Journal of immunology.

[19]  K. Schollmeier,et al.  Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo application , 1990 .

[20]  C. Smith,et al.  Reverse signaling via CD30 ligand. , 1996, Journal of immunology.

[21]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[22]  G. Ledderose,et al.  Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha , 1995, Blood.

[23]  P. Scheurich,et al.  TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. , 1993, Lymphokine and cytokine research.

[24]  C. Haslett,et al.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators , 1993, Journal of leukocyte biology.

[25]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.